MXPA05011078A - Bromuro y sus cristales. - Google Patents

Bromuro y sus cristales.

Info

Publication number
MXPA05011078A
MXPA05011078A MXPA05011078A MXPA05011078A MXPA05011078A MX PA05011078 A MXPA05011078 A MX PA05011078A MX PA05011078 A MXPA05011078 A MX PA05011078A MX PA05011078 A MXPA05011078 A MX PA05011078A MX PA05011078 A MXPA05011078 A MX PA05011078A
Authority
MX
Mexico
Prior art keywords
crystal
type
beta
bromide
medicine production
Prior art date
Application number
MXPA05011078A
Other languages
English (en)
Inventor
Akira Matsuhisa
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of MXPA05011078A publication Critical patent/MXPA05011078A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bromuro de 1-(2-metoxietil -2-metil-4, 9-dioxo-3 -(pirazin-2 -ilmetil)-4, 9-dihidro- 1H-nafto [2, 3-d]imidazol -3-io y sus cristales. En particular, sus cristales de tipo alfa y de tipo beta, que no muestran absorcion de humedad, y son superiores en estabilidad, de tal forma que son utiles como ingredientes basicos para la produccion de medicinas. Entre ellos, el crital tipo beta es mas estable y es extremadamente util como un ingrediente basico para la produccion de medicinas.
MXPA05011078A 2003-04-15 2004-04-14 Bromuro y sus cristales. MXPA05011078A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003109793 2003-04-15
PCT/JP2004/005321 WO2004092160A1 (ja) 2003-04-15 2004-04-14 臭化物及びその結晶

Publications (1)

Publication Number Publication Date
MXPA05011078A true MXPA05011078A (es) 2006-01-24

Family

ID=33295930

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011078A MXPA05011078A (es) 2003-04-15 2004-04-14 Bromuro y sus cristales.

Country Status (7)

Country Link
US (1) US20060223831A1 (es)
EP (1) EP1614686B1 (es)
KR (1) KR101015034B1 (es)
CN (1) CN100343248C (es)
CA (1) CA2522486C (es)
MX (1) MXPA05011078A (es)
WO (1) WO2004092160A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2661618A1 (en) 2006-08-25 2008-02-28 Astellas Pharma Inc. Stabilized pharmaceutical composition
US7618992B2 (en) * 2006-12-29 2009-11-17 Astellas Pharma Inc. Method of treating cancer by co-administration of anticancer agents
EP2539139B9 (en) * 2010-02-22 2016-08-03 Pirelli Tyre S.p.A. Process and apparatus for unwinding an elongated element provided with two service fabrics in order to build tyres for vehicle wheels
TWI511967B (zh) 2010-06-16 2015-12-11 Takeda Pharmaceutical 醯胺化合物之結晶
JP2014156400A (ja) * 2011-05-24 2014-08-28 Astellas Pharma Inc 腫瘍の画像診断用標識誘導体
WO2013148649A1 (en) 2012-03-26 2013-10-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of survivin antagonists in polyomavirus-related disease
US9732154B2 (en) 2014-02-28 2017-08-15 Janssen Biotech, Inc. Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
US9603927B2 (en) 2014-02-28 2017-03-28 Janssen Biotech, Inc. Combination therapies with anti-CD38 antibodies
BR112017024877A2 (pt) 2015-05-20 2019-09-17 Janssen Biotech, Inc. anticorpo anti-cd38 e seu uso no tratamento de amiloidose de cadeia leve e outras malignidades hematológicas positivas para cd38
WO2016209921A1 (en) 2015-06-22 2016-12-29 Janssen Biotech, Inc. Combination therapies for heme malignancies with anti-cd38 antibodies and survivin inhibitors
MA43187B1 (fr) 2015-11-03 2021-02-26 Janssen Biotech Inc Formulations sous-cutanée d'anticorps anti-cd38 et leurs utilisations
WO2018218633A1 (en) 2017-06-02 2018-12-06 Beijing Percans Oncology Co. Ltd. Combination therapies for treating cancers
US11618787B2 (en) 2017-10-31 2023-04-04 Janssen Biotech, Inc. Methods of treating high risk multiple myeloma
WO2019195959A1 (en) 2018-04-08 2019-10-17 Cothera Biosciences, Inc. Combination therapy for cancers with braf mutation
EP3590935A1 (en) 2018-07-06 2020-01-08 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Fused imidazolium derivatives for use in the treatment of colorectal cancer
WO2023133703A1 (en) * 2022-01-11 2023-07-20 Chun Jiang Apoptosis inhibitor salts for cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001232286A1 (en) * 2000-02-15 2001-08-27 Yamanouchi Pharmaceutical Co..Ltd. Fused imidazolium derivatives
JP3634328B2 (ja) * 2001-08-10 2005-03-30 山之内製薬株式会社 縮合イミダゾリウム誘導体を含む医薬組成物

Also Published As

Publication number Publication date
US20060223831A1 (en) 2006-10-05
CN1791595A (zh) 2006-06-21
KR20060006032A (ko) 2006-01-18
CA2522486C (en) 2011-02-22
CA2522486A1 (en) 2004-10-28
KR101015034B1 (ko) 2011-02-16
EP1614686A1 (en) 2006-01-11
WO2004092160A1 (ja) 2004-10-28
EP1614686B1 (en) 2014-05-07
EP1614686A4 (en) 2011-01-19
CN100343248C (zh) 2007-10-17

Similar Documents

Publication Publication Date Title
MXPA05011078A (es) Bromuro y sus cristales.
NZ501112A (en) Substituted pyrazoles as p38 kinase inhibitors
MY134568A (en) Cb2 receptor agonists
AU2003262262A1 (en) Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
EA200400147A1 (ru) Сборный многосекционный контейнер
MXPA03007712A (es) Sales farmaceuticas.
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
HUP0402489A3 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
IL164209A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
IL166620A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
MY129613A (en) Cannabinoid receptor binding compounds
EA200100554A1 (ru) Замещенные пиразолы как ингибиторы p38 киназы
HK1079519A1 (en) Furyl compounds
HUP0301651A2 (en) Indolylmaleimide derivatives, pharmaceutical compositions containing them, process for producing them and their use
EE04836B1 (et) N-piperidino-5-(4-klorofenüül)-1-(2,4-diklorofenüül)-4-metüülpürasool-3-karboksamii di kasutamine ravimtoodete valmistamiseks, aitamaks loobuda tubakatarbimisest
HUP0303069A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and their use
NO20002391D0 (no) Corticotropin-frigjøringsfaktorantagonister
IL133824A0 (en) Tetrazole derivatives, medicaments containing same and use thereof
ATE177319T1 (de) Therapeutische mischung aus vitamin und calcium in form einer galenischen einzeldosistablette, verfahren zu ihrer herstellung und ihre verwendung
RS51599B (en) NEW CRYSTAL ANHYDRATE WITH ANTICHOLINERGY ACTION
NO20042158L (no) Substituert 4-fenyl-tetrahydroisokinoliner, fremgangsmate for fremstilling derav, anvendelse derav som medikamenter, i tillegg til medikamenter inneholdende samme
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
AU2001273384A1 (en) 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
PL329027A1 (en) Derivatives of benzopyrane exhibiting antagonistic activity in respect to leucotriene

Legal Events

Date Code Title Description
FG Grant or registration